Back to Results
First PageMeta Content
European Federation of Pharmaceutical Industries and Associations / Innovative Medicines Initiative / Novartis / UCB / Boehringer Ingelheim / Sanofi / Pharmaceutical sciences / Pharmaceutical industry / Europe


PRESS RELEASE ANNOUNCING THE START OF AETIONOMY AETIONOMY organizes knowledge about dementia to develop new drugs and therapies BRUSSELS. In January the AETIONOMY consortium started a project aiming to develop a new way
Add to Reading List

Document Date: 2014-02-18 05:19:35


Open Document

File Size: 399,61 KB

Share Result on Facebook

City

BRUSSELS / /

Company

Aventis / Novartis / Sanofi / Boehringer Ingelheim / UCB Pharma / EFPIA Pharmaceutical / /

Currency

EUR / /

/

Facility

Fraunhofer Institute / Bioinformatics Fraunhofer Institute / /

IndustryTerm

pharmaceutical industry association / finance / imaging / /

MedicalCondition

Alzheimer’s disease / broad disease / dementia / disease / movement disorder / Parkinson’s disease / diseases / memory loss / /

Organization

EFPIA / Fraunhofer Institute for Algorithms and Scientific Computing / Scientific Computing / European Union / Fraunhofer Institute for Algorithms / /

Person

Martin Hofmann-Apitius / Duncan McHale / Laurent Schots / /

/

Position

author / Professor / Head of the Department / /

Technology

Bioinformatics / pdf / /

URL

www.aetionomy.eu / http /

SocialTag